Breast Cancer
Showing NaN - NaN of 159
Breast Cancer Trial in Cleveland (Survey, Education Session)
Recruiting
- Breast Cancer
- Survey
- Education Session
-
Cleveland, OhioCleveland Clinic, Case Comprehensive Cancer Center
Jul 25, 2022
Breast Cancer Trial in Worldwide (biological, drug, other, procedure)
Active, not recruiting
- Breast Cancer
- nivolumab
- +6 more
-
Mobile, Alabama
- +255 more
Jul 21, 2022
Breast Cancer Trial in Worldwide (Elacestrant, Standard of Care)
Active, not recruiting
- Breast Cancer
- Elacestrant
- Standard of Care
-
Tucson, Arizona
- +167 more
Jul 19, 2022
Breast Cancer Trial in Worldwide (Ribociclib, Letrozole, Goserelin)
Quality of Life in Female Breast Cancer Survivors and Their
Completed
- Breast Cancer
- +5 more
- cognitive assessment
- +2 more
-
Monterey, California
- +103 more
Jun 8, 2022
Breast Cancer Trial in Cleveland (3D MR Fingerprinting scan)
Active, not recruiting
- Breast Cancer
- 3D MR Fingerprinting scan
-
Cleveland, OhioUniversity Hospitals Cleveland Medical Center, Case Comprehensiv
Jun 6, 2022
Breast Cancer, Malignant Tumor of Breast Trial in Cleveland (Immediate Breast Reconstruction, Delayed Breast Reconstruction,
Withdrawn
- Breast Cancer
- Malignant Neoplasm of Breast
- Immediate Breast Reconstruction
- +2 more
-
Cleveland, OhioCleveland Clinic, Case Comprehensive Cancer Center
May 16, 2022
Breast Cancer, Mastectomy; Lymphedema, Pain, Shoulder Trial in Cleveland (Myofascial Massage, Light Touch)
Recruiting
- Breast Cancer
- +3 more
- Myofascial Massage
- Light Touch
-
Cleveland, OhioMetroHealth Medical Center
May 3, 2022
Breast Cancer Trial in Worldwide (Trastuzumab deruxtecan (T-DXd), Ado-trastuzumab emtansine (T-DM1))
Active, not recruiting
- Breast Cancer
- Trastuzumab deruxtecan (T-DXd)
- Ado-trastuzumab emtansine (T-DM1)
-
Los Angeles, California
- +163 more
Apr 1, 2022
Breast Cancer Trial in Worldwide (Palbociclib, Standard Adjuvant Endocrine Therapy)
Active, not recruiting
- Breast Cancer
- Palbociclib
- Standard Adjuvant Endocrine Therapy
-
Mobile, Alabama
- +437 more
Mar 21, 2022
Breast Cancer Prior to Decisions on Preventive Therapy Uptake,
Enrolling by invitation
- Breast Cancer
- Polygenic Risk Score
-
Scottsdale, Arizona
- +4 more
Apr 5, 2022
Advanced Solid Tumor, Gynecologic Cancer, Breast Cancer Trial in United States (PY314, Combination Therapy: PY314 +
Recruiting
- Advanced Solid Tumor
- +8 more
- PY314
- Combination Therapy: PY314 + Pembrolizumab
-
Scottsdale, Arizona
- +12 more
Mar 28, 2022
Breast Cancer, Physical Activity Trial in Cleveland (Aerobic Training - Fixed Schedule, Resistance Training - Fixed Schedule,
Completed
- Breast Cancer
- Physical Activity
- Aerobic Training - Fixed Schedule
- +6 more
-
Cleveland, Ohio
- +2 more
Mar 21, 2022
Head and Neck Squamous Cell Carcinoma, Breast Cancer, Sarcoma Trial in United States (Durvalumab, Tremelimumab, Poly ICLC)
Completed
- Head and Neck Squamous Cell Carcinoma
- +10 more
- Durvalumab
- +2 more
-
Atlanta, Georgia
- +6 more
Mar 1, 2022
Advanced Solid Tumors, Solid Tumors, Ovarian Cancer Trial in Australia, United States (TALZENNA capsule, Talazoparib soft gel
Active, not recruiting
- Advanced Solid Tumors
- +7 more
- TALZENNA capsule
- Talazoparib soft gel capsule
-
Encinitas, California
- +31 more
Feb 14, 2022
Advanced Cancer, Ovarian Cancer, Breast Cancer Trial in United States (COM701, COM701 with Opdivo (Nivolumab).)
Recruiting
- Advanced Cancer
- +9 more
- COM701
- COM701 with Opdivo (Nivolumab).
-
Los Angeles, California
- +10 more
Jan 25, 2022
Breast Cancer Trial in Worldwide (Trastuzumab deruxtecan (DS-8201a), Capecitabine, Eribulin)
Active, not recruiting
- Breast Cancer
- Trastuzumab deruxtecan (DS-8201a)
- +5 more
-
Chandler, Arizona
- +207 more
Jan 25, 2022
Breast Cancer Trial in Worldwide (Abemaciclib, Standard Adjuvant Endocrine Therapy)
Active, not recruiting
- Breast Cancer
- Abemaciclib
- Standard Adjuvant Endocrine Therapy
-
Birmingham, Alabama
- +611 more
Jan 21, 2022
Breast Cancer Trial in Canada, Puerto Rico, United States (pegfilgrastim, AC regimen, cyclophosphamide)
Active, not recruiting
- Breast Cancer
- pegfilgrastim
- +4 more
-
Anniston, Alabama
- +541 more
Jan 19, 2022
Breast Cancer Trial in Canada, Ireland, United States (Letrozole, Placebo)
Breast Cancer, Alopecia Trial in United States (PAXMAN Orbis Scalp Cooler, Control No treatment)
Active, not recruiting
- Breast Cancer
- Alopecia
- PAXMAN Orbis Scalp Cooler
- Control No treatment
-
Morristown, New Jersey
- +6 more
Jul 25, 2021
Breast Cancer Trial in United States (Imagio OA/US (US and OA/US), Imagio gray scale ultrasound)
Completed
- Breast Cancer
- Imagio OA/US (US and OA/US)
- Imagio gray scale ultrasound
-
Murrieta, California
- +15 more
Jun 23, 2021
[Ga-68]PSMA PET/MRI for the Assessment of PSMA-positive Tumors
Completed
- Prostate-specific Membrane Antigen Positive Tumors
- +3 more
- [Ga-68]PSMA PET/MR
-
Cleveland, OhioUniversity Hospitals, Case Comprehensive Cancer Center
May 5, 2021